DK1096951T3 - Anvendelse af bromelainproteaser til inhiberingen af blodkoaguleringen - Google Patents
Anvendelse af bromelainproteaser til inhiberingen af blodkoaguleringenInfo
- Publication number
- DK1096951T3 DK1096951T3 DK98942559T DK98942559T DK1096951T3 DK 1096951 T3 DK1096951 T3 DK 1096951T3 DK 98942559 T DK98942559 T DK 98942559T DK 98942559 T DK98942559 T DK 98942559T DK 1096951 T3 DK1096951 T3 DK 1096951T3
- Authority
- DK
- Denmark
- Prior art keywords
- proteases
- blood coagulation
- inhibition
- inhibiting
- bromelaine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1998/004406 WO2000003729A1 (de) | 1998-07-15 | 1998-07-15 | Verwendung von bromelainproteasen zur hemmung der blutgerinnung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1096951T3 true DK1096951T3 (da) | 2002-10-21 |
Family
ID=8167005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98942559T DK1096951T3 (da) | 1998-07-15 | 1998-07-15 | Anvendelse af bromelainproteaser til inhiberingen af blodkoaguleringen |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6803038B1 (da) |
| EP (1) | EP1096951B1 (da) |
| AT (1) | ATE222121T1 (da) |
| AU (1) | AU9066198A (da) |
| CA (1) | CA2333252C (da) |
| DE (1) | DE59805215D1 (da) |
| DK (1) | DK1096951T3 (da) |
| ES (1) | ES2182356T3 (da) |
| PT (1) | PT1096951E (da) |
| WO (1) | WO2000003729A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL165334A0 (en) * | 2004-11-22 | 2006-01-15 | Mediwound Ltd | Debriding composition from bromelain and methods of producing same |
| EP2036978A1 (en) * | 2007-09-14 | 2009-03-18 | URSAPHARM Arzneimittel GmbH & Co. KG | Recombinant preparation of selected bromelain fractions |
| DE102008062136B4 (de) * | 2008-12-16 | 2012-05-03 | Kamamed Ug | Pharmazeutische Zusammensetzung auf Basis von Peptid aus Kamelmilch |
| ES2909565T3 (es) | 2016-01-31 | 2022-05-09 | Mediwound Ltd | Composición desbridante para el tratamiento de heridas |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63295515A (ja) * | 1987-05-26 | 1988-12-01 | Kao Corp | 腸溶性抗血液凝固・血栓溶解製剤 |
| DE4130221C2 (de) | 1991-09-11 | 1997-08-07 | Mucos Pharma Gmbh | Verwendung von proteolytischen Enzymen zur Herstellung eines Medikaments zur Behandlung von Autoimmun-Krankheiten, an deren Entstehung Proteine mit einer C¶H¶2-Domäne beteiligt sind |
| SG42846A1 (en) * | 1992-06-30 | 1997-10-17 | Cortecs Ltd | Use of enzymes especially bromelain in the treatment of diarrhoea |
| DE4302060A1 (de) | 1993-01-26 | 1994-07-28 | Mucos Pharma Gmbh & Co | Verwendung von Bromelain zur Krebstherapie und/oder Metastasen-Prophylaxe |
| GB9313188D0 (en) * | 1993-06-25 | 1993-08-11 | Cortecs Ltd | Medical use of enzymes |
| GB9403344D0 (en) * | 1994-02-22 | 1994-04-13 | Cortecs Ltd | Medical application of bromelain |
| JP2001513636A (ja) * | 1997-02-25 | 2001-09-04 | コルテクス（ユーケイ）リミティッド | ブロメラインの成分 |
| EP1865055B1 (en) * | 1997-02-25 | 2012-12-05 | Sarantis Pty Ltd | Component of bromelain |
-
1998
- 1998-07-15 US US09/674,738 patent/US6803038B1/en not_active Expired - Fee Related
- 1998-07-15 DE DE59805215T patent/DE59805215D1/de not_active Expired - Lifetime
- 1998-07-15 EP EP98942559A patent/EP1096951B1/de not_active Expired - Lifetime
- 1998-07-15 AU AU90661/98A patent/AU9066198A/en not_active Abandoned
- 1998-07-15 DK DK98942559T patent/DK1096951T3/da active
- 1998-07-15 CA CA002333252A patent/CA2333252C/en not_active Expired - Fee Related
- 1998-07-15 AT AT98942559T patent/ATE222121T1/de active
- 1998-07-15 WO PCT/EP1998/004406 patent/WO2000003729A1/de active IP Right Grant
- 1998-07-15 PT PT98942559T patent/PT1096951E/pt unknown
- 1998-07-15 ES ES98942559T patent/ES2182356T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000003729A1 (de) | 2000-01-27 |
| EP1096951B1 (de) | 2002-08-14 |
| DE59805215D1 (de) | 2002-09-19 |
| US6803038B1 (en) | 2004-10-12 |
| ATE222121T1 (de) | 2002-08-15 |
| EP1096951A1 (de) | 2001-05-09 |
| ES2182356T3 (es) | 2003-03-01 |
| AU9066198A (en) | 2000-02-07 |
| CA2333252C (en) | 2008-11-25 |
| CA2333252A1 (en) | 2000-01-27 |
| PT1096951E (pt) | 2003-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE50014190D1 (de) | Verwendung von phthalazin-derivaten zur behandlung neurodegenerativer krankheiten | |
| TR200001954T2 (tr) | Faktör XA'nın önleyicileri olarak indol türevleri. | |
| ATE277612T1 (de) | Arylharnstoffderivate zur behandlung von inflammatorischen oder immunomodulatorischen erkrankungen | |
| DK0968182T3 (da) | Hydroxam- og carboxylsyrederivater med MMP- og TNF-inhiberende aktivitet | |
| BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
| ATE286053T1 (de) | Naphthyridinone zur hemmung der durch protein- tyrosin-kinase und zellzyklus kinase hervorgerufenen zellvermehrung | |
| BR0013966A (pt) | Compostos espiroeterocìclicos úteis como inibidores reversìveis de proteases de cisteìna | |
| ES2155817T1 (es) | Inhibicion de la actividad de la quinasa p38 utilizando ureas heterociclicas sustituidas con arilo y heteroarilo. | |
| DE60023266D1 (de) | Serinprotease-inhibitoren | |
| ES2117123T3 (es) | Derivados de aminocetilmercaptoacetilamida utilizados como inhibidores de la encefalinasa y del enzima de conversion de angiotensina. | |
| TR199902766T2 (xx) | Proteaz inhibit�rleri. | |
| ATE335485T1 (de) | Quinolin-enthaltende alpha-ketoamid-basierte inhibitoren von cystein- und serin protease | |
| DE60139466D1 (de) | Behandlung von diabetes | |
| DE60137978D1 (de) | Zusammensetzung zur förderung des haarwachstums | |
| TR199802638T2 (xx) | Kanser tedavisinde naaladase inhibit�rleri kullan�m�. | |
| DE69830842D1 (de) | Peptide als kalium kanalaktivatoren | |
| AU5628800A (en) | Substituted benzamide inhibitors of rhinovirus 3c protease | |
| ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
| DK1096951T3 (da) | Anvendelse af bromelainproteaser til inhiberingen af blodkoaguleringen | |
| ATE290857T1 (de) | Bretyliumhaltige zusammensetzungen und kits und deren verwendung zur vorbeugung und behandlung cardiovaskulärer erkrankungen | |
| ATE510911T1 (de) | Prothrombin aktivierendes protein | |
| WO1999058098A3 (en) | HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO | |
| DK0942992T3 (da) | O-fucosyltransferase | |
| DE59813914D1 (de) | Mittel zur behandlung und/oder prophylaxe von mikrozirkulationsstörungen | |
| ATE440108T1 (de) | Plasmin-inhibitoren von der australischen braunen schlange, pseudonaja textilis textilis |